Visualization of Endoplasmic Reticulum Localized mRNAs in Mammalian Cells

Podsumowanie

Here we describe a method to visualize endoplasmic reticulum-associated mRNAs in mammalian tissue culture cells. This technique involves the selective permeabilization of the plasma membrane with digitonin to remove cytoplasmic contents followed by fluorescent in situ hybridization to detect either bulk poly(A) mRNA or specific transcripts.

Streszczenie

In eukaryotes, most of the messenger RNAs (mRNAs) that encode secreted and membrane proteins are localized to the surface of the endoplasmic reticulum (ER). However, the visualization of these mRNAs can be challenging. This is especially true when only a fraction of the mRNA is ER-associated and their distribution to this organelle is obstructed by non-targeted (i.e. "free") transcripts. In order to monitor ER-associated mRNAs, we have developed a method in which cells are treated with a short exposure to a digitonin extraction solution that selectively permeabilizes the plasma membrane, and thus removes the cytoplasmic contents, while simultaneously maintaining the integrity of the ER. When this method is coupled with fluorescent in situ hybridization (FISH), one can clearly visualize ER-bound mRNAs by fluorescent microscopy. Using this protocol the degree of ER-association for either bulk poly(A) transcripts or specific mRNAs can be assessed and even quantified. In the process, one can use this assay to investigate the nature of mRNA-ER interactions.

Wprowadzenie

In eukaryotes, mRNA encoding secreted and membrane proteins can be targeted to the ER co-translationally by the signal recognition particle^1,2 and can be maintained on the ER via the direct interactions between ribosomes and translocons during the translation^3,4. However, whether mRNAs can be targeted and maintained on the ER independent of either ribosomes or translation was unclear until very recently. Previous studies attempted to address whether there is translation-independent mRNA association with the ER using cellular fractionation techniques. Because harsh chemical conditions were required to disassociate ribosomes from ER derived vesicles, which might disrupt the potentially delicate mRNA-ER association, these studies were inconclusive, providing evidence for^5-8 and against^9,10 ribosomal-independent anchoring of mRNA to the ER.

To circumvent these problems we have developed a protocol to isolate and image ER-bound mRNAs. This procedure involves a mild extraction treatment, which effectively removes all the cytoplasmic content of the cell (including non ER-bound mRNAs) while simultaneously preserving the ER morphology and all of its associated molecules. Using this protocol we have demonstrated that a subset of mRNAs are targeted and then maintained on the ER independently of ribosomes or translation¹¹.

Access restricted. Please log in or start a trial to view this content.

Protokół

1. Preparation of Materials for Extraction

1. Preparation of Cells
   1. Seed tissue culture cells on acid-treated coverslips for at least one day prior to the experiment. We use COS-7 or U2OS, as these two cell lines exhibit robust production of secreted protein and have a well defined ER. Note that to achieve high extraction efficiency, cells should not exceed 80% confluency on the coverslip on the day of the experiment.
   2. If a particular exogenous mRNA is being investigated, cells are transfected one day after seeding with plasmids containing the gene of interest using standard transfection protocols. The cells are then allowed to express the mRNA for at least 18 hr prior to extraction.
2. Treating the Cells with Translation Inhibitors
   1. To test the effect of intact ribosomes on the maintenance of mRNAs association with the ER, cells can be treated with translation inhibitors that disrupt the association of ribosomes with the mRNA¹¹.
   2. Inhibitors of translation initiation, such as homoharringtonin (HHT), pactamycin, or 2-(4-methyl-2,6-dinitroanilino)-N-methylpropionamide (MDMP), prevent new ribosomes from associating with the transcript while simultaneously allowing engaged ribosomes to complete translation^12-14. Since the translation rate for most proteins in mammalian cells is 5 amino acids per second, regardless of codon usage or mRNA length¹⁵, a treatment of 30 min should clear ribosomes off of messages with open reading frames as long as 27,000 nucleotides (coding for proteins as long as 9,000 amino acids).
   3. Inhibitors such as puromycin promote the premature ejection of the nascent chain and thus disrupt polysomes¹². However to completely disrupt the association of puromycin-treated ribosomes with the mRNA, magnesium chelators such as EDTA must be added to the digitonin extraction buffer¹¹.
   4. In this experiment, cells are treated with 200 μM puromycin, 5 μM HHT, or control medium for 30 min prior to extraction.
3. Preparation of Digitonin Extraction Buffer. To visualize ER-localized mRNAs without the obstruction of free (i.e. cytoplasmic, non-ER-associated) transcripts, we selectively permeabilize the cell with digitonin, a steroid glycoside that interacts preferentially with 3β-hydroxysterols. At low concentrations, digitonin selectively permeabilizes portions of the plasma membrane, causing 'leakiness'¹⁶. In contrast, the ER membrane and nuclear envelope, which are poor in cholesterol, are left intact^16,17.
   1. Digitonin (Sigma Aldrich) powder is dissolved in distilled water at 5% weight/volume and this stock solution is aliquoted into small volumes and stored in -20 °C. In our experience, multiple freeze-thaw cycles decreases the efficiency of dissolved digitonin.
   2. A stock solution of 10x CHO buffer (1x working solution concentration: 115 mM KAc, 25 mM HEPES pH 7.4, 2.5 mM MgCl₂, 2 mM EGTA and 150 mM Sucrose) is prepared with RNase-free reagents and stored at -20 °C. A working solution (1x CHO buffer) is prepared by diluting the stock solution with RNase-free water and can be stored at 4 °C.

2. Digitonin Extraction

1. Preparing Extraction Solutions
   1. A heating block with a flat surface is pre-heated to 40 °C and maintained at this temperature during to the extraction.
   2. To form a flat working surface that is RNase free, the heating block is moistened with some water and overlaid with a fresh piece of parafilm M (Bemis Company, Inc). Air bubbles between the parafilm sheet and heating block are smoothed out using RNase-free gloves and kimwipes (VWR).
   3. 1x CHO buffer is warmed to 37 °C by incubating in a water bath.
   4. 6-well plates are used to wash and fix the cells. Each row of 3 wells is used for one cover-slip. To the first two wells in the row, 2 ml of warmed CHO buffer is added. To the last well, 2 ml of the fixation solution (PBS + 4% paraformaldehyde (Electron Microscope Sciences)) is added. This tray can be stored in the 37 °C incubator until the cells are ready for extraction.
   5. Digitonin extraction solution is prepared by diluting the stock digitonin solution to 0.025% with warm CHO buffer just prior to use. Again note that for puromycin-treated cells, the extraction buffer must additionally contain 20 mM EDTA to efficiently disrupt ribosomes¹¹. Drops of 100 μl of the extraction solution are placed on the parafilm-covered heating block immediately before extraction.
2. Digitonin Extraction and Cell Fixation
   1. Remove the cells from the 37 °C incubator.
   2. During the extraction process, coverslips are manipulated with the help of jewler's forceps. With the forceps pick up the coverslip and dip it into the first and then the second well containing CHO buffer to wash of the growth medium.
   3. Quickly blot off excess buffer off the back side of the coverslip with a kimwipe and immediately place the coverslip, cell side facing down, on the extraction solution.
   4. After 10 sec, pick up the coverslip with the forceps and immediately transfer it, cell side facing up, to the well containing the 4% paraformaldehyde fixing buffer.
   5. Let the sample incubate in fixative for at least 15 min at room temperature.
3. Preparation of Unextracted Control Cells. To determine the total amount of mRNA in the cytoplasm it is a good idea to prepare an unextracted control sample.
   1. Cells grown on coverslips are prepared as above (see section 2.2), except that the digitonin extraction step (2.2.3) is skipped.
   2. After fixation, the un-extracted cells need to be permeabilized in PBS + 0.1% Triton X-100 for 15 min at room temperature.

3. FISH Staining

1. Designing probes for fluorescence in situ hybridization
   1. The primary sequence of the mRNA of interested is folded using RNA secondary structure prediction software, such as RNAstructure 5.0¹⁸. The mRNA folds are visually assessed to identify a region of about 50 nucleotides that is free of major secondary structures.
   2. The reverse complement of this region is synthesized with an Alexa546 fluorophore attached to the 5' end of the probe (purchased from Integrated DNA Technologies).
   3. The probe is diluted with RNase-free water to a stock concentration of 100 μM which can be stored at -20 °C.
2. Staining with FISH probes
   1. Note that although the digitonin-extracted cells do not require further permeabilization, treating these fixed samples with 2 ml of 0.1% Triton X-100 diluted in PBS for 15 min at room temperature prior to FISH staining, helps to reduce the background signal.
   2. The slides are then washed twice with PBS to remove any residual paraformaldehyde or Triton X-100.
   3. The cells are then washed twice with 25% to 60% formamide in 1X Sodium Citrate Buffer (150 mM NaCl and 15 mM sodium citrate). Generally, for specific FISH probes that are 50-60 nucleotides in length, 60% formamide is used, but for poly(A) mRNA staining with oligo(dT) FISH probe, the level of formamide is reduced down to 25%.
   4. To prepare the staining chamber, the bottom of a 150 mm Petri dish is covered with water and a piece of parafilm is floated on the water. The water is removed by turning the dish over, thus allowing the parafilm to adhere to the bottom of the dish. Air bubbles are manually removed with kimwipes.
   5. For each coverslip to be stained, pipette a 100 μl drop of the hybridization solution containing FISH probe of interest onto the parafilm in the staining chamber. The stock FISH probe is diluted with 25% to 60% formamide in hybridization buffer (1x SSC, 100 mg/ml dextran sulphate, 1 mg/ml yeast tRNA, 5mM vanadyl riboside complex, 25-60% formamide) to a working concentration of 0.2 μM. Note that the amount of formamide should be optimized for the particular probe being used and is present at the same concentration as in the SSC wash buffer (see step 3.3.3).
   6. The coverslip is placed cell side face down onto the FISH solution in the staining chamber and incubated for 5-24 hr at 37 °C in a humidified chamber such as the tissue culture incubator.
3. Washing and mounting the stained samples
   1. To prepare an RNase free washing area, lay down a strip of parafilm on a level flat surface, such as a lab bench. To ensure that the parafilm is flat, wet the level surface, place the parafilm on top and manually remove any air bubbles with kimwipes.
   2. The staining chamber is removed from the incubator and placed on a flat level surface. The coverslips are then floated by pipetting approximately 500 μl of FISH wash buffer near the edge of each coverslip. The solution will be drawn in-between the coverslip and the parafilm via capillary action.
   3. For each coverslip, 1 ml of wash buffer (1x SCC with 25-60% formamide, see step 3.3.3) is pipetted onto the washing area parafilm (see step 3.4.1).
   4. Using forceps, the coverslips are removed from the staining chamber and each is placed onto the drop of wash buffer and incubated at room temperature for 5 min. The washing process is repeated 3 times.
   5. Glass slides are washed with 70% ethanol, and dried with kimwipes.
   6. For each coverslip, 25 μl of mounting solution (DAPI Fluoromount G, Southern Biotech) is pipetted onto the slide. Note that this solution contains 4',6-diamidino-2-phenylindole (DAPI), which stains DNA and allows for the visualization of nuclei.
   7. Using forceps and kimwipes, the back of the coverslip is dried and excess FISH wash buffer is blotted off without drying the sample. Each coverslip is then placed cell side facing down, onto the drop of mounting solution.
   8. Mounted samples are then labeled and can be store at 4 °C.

4. Imaging and Quantification

1. Imaging
   1. An epifluorescence microscope is used to image the cells following FISH staining. The transfected cell can be differentiated from untransfected cells by bright fluorescence signal in the appropriate channel. Ideally, each acquired field will also contain an untransfected cell to be used to determine the background fluorescence for quantification.
   2. For each field images of the FISH and DAPI channel are acquired. In addition, if the cells are co-stained with protein markers, an image of the immunofluorescence channel is also acquired. Note that digitonin extraction can also be used to visualize ER-bound ribosomes and proteins¹¹.
   3. To ensure that the fluorescence intensities between fields can be compared, the exposure time for each channel should remain constant for each set of experiment.
   4. Again to ensure that the fluorescent intensities between cells on different coverslips can be compared, the day-to-day changes in epiluminescence intensity or decay in the FISH signal should be minimized by imaging all of the coverslips in a single sitting.
2. Quantification. To quantify the amount of mRNA that is localized on the ER, we use Nikon NIS Element software. However other image analysis software such as ImageJ can be used.
   1. Using the Nikon NIS ELEMENT image analysis tool, the cell periphery and the nucleus are outlined as separate Region of Interests (ROIs).
   2. For each ROI, the fluorescent intensity (I_T for the total cell intensity and I_N for the nuclear intensity) and the area (A_T and A_N) are recorded and exported to an excel spreadsheet.
   3. For each image, the background fluorescent intensity (I_B) is determined by recording the intensity of a non-transfected cell. If poly(A) mRNA levels are being analyzed, a cell-free area is selected.
   4. The total amount of ER (in extracted cells) or cytoplasmic (in unextracted cells) fluorescence is calculated by the formula:
      [A_T][ I_T - I_B]- [A_N][ I_N - I_B]
   5. The nuclear staining intensity can also be calculated and used as internal control between various treatments. Since nuclei are not affected by digitonin treatment¹⁷ or ribosome disruption¹¹, the amount of nuclear mRNA should remain constant between each of these treatments. To calculate nuclear fluorescence the following formula is used:
      [A_N][ I_N - I_B]
   6. The percent of cytoplasmic mRNA that is ER-targeted can be calculated by taking the average ER fluorescence of 30-40 extracted cells (see 4.2.4) divided by the average cytoplasmic fluorescence from 30-40 unextracted cells (again see 4.2.4). It is critical that the extracted and unextracted cells are prepared, stained and imaged in parallel.

Access restricted. Please log in or start a trial to view this content.

Wyniki

To determine the percentage of mRNA that is ER-associated, COS-7 cells that were transfected with plasmids that contained the placental alkaline phosphatase (ALPP) or cytochrome P450-8B1 (CYP8B1) were either extracted with digitonin and then fixed, or directly fixed (see Figure 1, compare "Unextracted Ctrl" to "Extracted Ctrl"). The non-nuclear fluorescence was quantified in both samples and the fraction of ER-associated mRNA was calculated (Figure 2)....

Access restricted. Please log in or start a trial to view this content.

Dyskusje

The localization of mRNAs to various subcellular sites, through the interaction of transcripts with mRNA localization proteins, is a widespread phenomenon important for the proper sorting of proteins to their final destination, and for the fine tuning of gene expression to the local requirements of a subcellular region^19,20.

Using the assay described here, we revisited the question of whether mRNAs that encode secretory proteins can be maintained on the ER in the presence or absence...

Access restricted. Please log in or start a trial to view this content.